Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharm-country crawled time : 14:30 save search
Teladoc Health to Participate in Upcoming Investor Conference - March 8, 2024
Published: 2024-03-08 (Crawled : 14:30) - biospace.com/
TDOC S | $13.74 3.31% 0.0% 4M
|
Health Services
|
| O: 1.37%
H: 1.74%
C: -0.9%
conference health
Arbutus to Participate in Two Upcoming Investor Conferences - March 8, 2024
Published: 2024-03-08 (Crawled : 14:30) - biospace.com/
ABUS | $2.74 3.79% 3.65% 1.1M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
Citius Pharmaceuticals, Inc. Secures $2.4 million through New Jersey Economic Development Program
Published: 2024-03-07 (Crawled : 14:30) - biospace.com/
CTXR | $0.772 5.15% 4.9% 670K
|
Health Technology
|
| O: 0.7%
H: 4.13%
C: 3.61%
million program
VYNE Therapeutics to Present Results of the Phase 1b Trial for VYN201 at the 2024 Global Vitiligo Foundation Annual Scientific Symposium
Published: 2024-02-27 (Crawled : 14:30) - biospace.com/
VYNE | $2.345 -0.21% -0.21% 30K
|
Health Technology
|
| O: -0.43%
H: 1.71%
C: 1.28%
vyn201 symposium global trial therapeutics results
TG Therapeutics Announces Issuance of Additional Patents for BRIUMVI® (ublituximab-xiiy)Newly issued patents extend exclusivity of ublituximab through 2042
Published: 2024-02-27 (Crawled : 14:30) - biospace.com/
TGTX | $14.25 1.06% 1.05% 3.2M
|
Health Technology
|
| O: 3.44%
H: 1.77%
C: 0.65%
briumvi therapeutics
NRx Pharmaceuticals, Inc. Announces Pricing of $1.5 Million Underwritten Public Offering of Common Stock Together with investor Commitment for Additional $1 million
Published: 2024-02-27 (Crawled : 14:30) - biospace.com/
NRXP 5 d | $3.1 3.33% 3.23% 110K
|
Manufacturing
|
| O: -31.5%
H: 5.02%
C: 0.38%
million offering
Kenvue to Present at the Consumer Analyst Group of New York Conference on February 23, 2024
Published: 2024-02-13 (Crawled : 14:30) - biospace.com/
KVUE 4 | $19.37 -1.07% 0.0% 20M
|
n/a
|
| O: -0.97%
H: 0.95%
C: -0.77%
conference group
Protagenic Therapeutics Achieves First Clinical Safety Milestone with its Novel Neuropeptide for the Potential Treatment of Stress-Related Disorders
Published: 2024-02-13 (Crawled : 14:30) - biospace.com/
PTIX 4 | $1.55 24.0% 19.35% 71K
|
Administrative and Support and ...
|
| O: 4.25%
H: 20.0%
C: -3.0%
first disorders treatment therapeutics potential milestone
Medicare Coverage Significantly Expanded for the Eversense E3 CGM System - February 12, 2024
Published: 2024-02-12 (Crawled : 14:30) - biospace.com/
SENS | $0.43 7.82% 0.12% 1.6M
|
Electronic Technology
|
| O: 0.2%
H: 10.25%
C: 7.24%
eversense system
The Cigna Group to Host Investor Day in New York City on March 7
Published: 2024-01-31 (Crawled : 14:30) - biospace.com/
CI | $352.65 -0.15% 0.0% 940K
|
Health Services
|
| O: 0.4%
H: 0.97%
C: 0.27%
day group city
Savara to Present at Two Upcoming Healthcare Conferences
Published: 2024-01-31 (Crawled : 14:30) - biospace.com/
SVRA | $4.675 -0.53% -0.53% 500K
|
Health Technology
|
| O: -0.2%
H: 2.28%
C: -1.98%
UroGen Initiates Submission of a Rolling NDA to the FDA for UGN-102
Published: 2024-01-24 (Crawled : 14:30) - biospace.com/
URGN | $14.51 0.97% 0.96% 220K
|
Health Technology
|
| O: 4.24%
H: 0.0%
C: -4.51%
ugn-102 fda submission
Bristol Myers Squibb Completes Acquisition of Mirati Therapeutics, Strengthening and Diversifying Oncology Portfolio
Published: 2024-01-23 (Crawled : 14:30) - biospace.com/
MS | News 0 d | $93.76 1.81% 0.12% 6.4M
|
Finance
|
| O: -0.07%
H: 1.38%
C: 1.25%
EVR | $196.1 2.09% 0.0% 510K
|
Finance
|
| O: 0.35%
H: 0.29%
C: -0.26%
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: 0.22%
H: 1.49%
C: 0.89%
acquisition
Petros Pharmaceuticals Demonstrates Positive Results Following Successful Completion of Initial Cohort of Phase 2 Equivalent Self-Selection Study for STENDRA (avanafil) Rx-to-OTC Switch
Published: 2024-01-17 (Crawled : 14:30) - biospace.com/
PTPI | $0.68 4.58% 4.38% 610K
|
|
| O: 21.31%
H: 5.41%
C: -19.59%
stendra positive pharmaceuticals results study
Amneal Launches Complex Generic Fluorometholone Ophthalmic Suspension
Published: 2024-01-10 (Crawled : 14:30) - biospace.com/
AMRX | $5.4 0.56% 0.56% 1.4M
|
Health Technology
|
| O: 0.0%
H: 0.7%
C: -3.16%
KORU Medical Systems to Participate in Piper Sandler’s 35th Annual Healthcare Conference
Published: 2023-11-29 (Crawled : 14:30) - biospace.com/
KRMD | $2.15 0.94% 0.93% 84K
|
Health Technology
|
| O: -0.44%
H: 3.72%
C: 2.0%
conference medical
Applied DNA Extends Application of Linea(TM) IVT Platform to saRNA (self-amplifying mRNA)
Published: 2023-11-16 (Crawled : 14:30) - biospace.com/
APDN | $0.2888 -12.49% -14.27% 810K
|
Commercial Services
|
| O: 6.25%
H: 0.0%
C: -0.94%
dna application platform
Arbutus to Present at Jefferies London Healthcare Conference - November 8, 2023
Published: 2023-11-08 (Crawled : 14:30) - biospace.com/
ABUS | $2.74 3.79% 3.65% 1.1M
|
Health Technology
|
| O: 3.89%
H: 1.6%
C: 0.0%
conference
Rallybio to Present at Upcoming Investor Conferences in November - November 8
Published: 2023-11-08 (Crawled : 14:30) - biospace.com/
RLYB | News | $1.84 3.96% 3.8% 240K
|
|
| O: -2.33%
H: 1.19%
C: -10.71%
Insmed To Present at Two November Conferences - November 8, 2023
Published: 2023-11-08 (Crawled : 14:30) - biospace.com/
INSM | $25.25 4.73% 4.51% 2.1M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: -2.82%
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.